- Home
- ARAI vs PASG Comparison
ARAI vs PASG Comparison
Compare ARAI & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARAI | PASG |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United States | United States |
| Employees | 51 | 27 |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0M | 14.8M |
| IPO Year | 2024 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ARAI | PASG |
|---|---|---|
| Price | $0.24 | $4.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $12.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 282.4K | 22.5K |
| Earning Date | 04-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $113,250.00 | N/A |
| Revenue This Year | $800.66 | N/A |
| Revenue Next Year | $650.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $3.29 |
| 52 Week High | $6.86 | $20.00 |
Technical Indicators
Market Signals| Indicator | ARAI | PASG |
|---|---|---|
| Relative Strength Index (RSI) | 46.37 | 53.49 |
| Support Level | $0.22 | $4.27 |
| Resistance Level | $0.26 | $4.95 |
| Average True Range (ATR) | 0.02 | 0.24 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 28.92 | 45.83 |
Price Performance
Historical ComparisonAbout ARAI Arrive AI Inc.
Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advance chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.
About PASG Passage Bio Inc.
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.